VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jun 20, 2007 -- Tekmira Pharmaceuticals Corporation ("Tekmira") (Toronto:TKM.TO - News) will provide a progress update at today's Annual General Meeting of Shareholders including its plan to have eight products in clinical development in the next 12-18 months, being advanced internally and in collaboration with corporate partners. The AGM presentation can be accessed from the Company's website (www.tekmirapharm.com) after the conclusion of today's meeting.
